MOTS-c and Mitochondrial Signaling: What Current Studies Show
PeptaBase Research Review | 2026-02-20
Introduction
MOTS-c is a mitochondrial peptide discovered in 2015. Unlike typical regenerative peptides, it's encoded in mitochondrial DNA itself, not nuclear DNA. Researchers are studying its role in metabolic signaling and stress responses.
The working theory: mitochondrial peptides like MOTS-c act as chemical messengers between mitochondria and the cell nucleus, signaling the cell's energy status.
Full research summaries are available in the PeptaBase entry: MOTS-c entry on PeptaBase
What MOTS-c Is
MOTS-c comes from the 12S rRNA region of mitochondrial DNA. Cells release it during stress, and it enters the nucleus to affect gene expression.
Interest in mitochondrial peptides has exploded recently because they seem to control how cells use energy.
Mechanisms Studied
AMPK activation
Studies show MOTS-c activates AMPK, a key enzyme that controls energy balance in cells.
Insulin sensitivity
When rodents receive MOTS-c, their insulin signaling improves in metabolic studies.
Exercise response
Evidence suggests mitochondrial peptides like MOTS-c rise during exercise-your body's way of signaling metabolic stress to itself.
Research Evidence
Studies examine MOTS-c in:
- Obesity and metabolic syndrome
- Insulin resistance
- Mitochondrial stress
Together, these suggest mitochondrial peptides are core to how your body adapts metabolism.
Research Protocol Observations
Protocols vary by the metabolic condition being studied, but typically measure glucose tolerance, insulin sensitivity, and mitochondrial signaling.
For detailed protocol summaries: MOTS-c entry on PeptaBase
Limitations
Almost all current data comes from animal models. We don't yet understand how mitochondrial peptides work in humans or whether they could be practical treatments.